Home / PDE8B Knockout Cell Lines

PDE8B Knockout Cell Lines

Gene: PDE8B

Official Full Name: phosphodiesterase 8Bprovided by HGNC

Gene Summary: The protein encoded by this gene is a cyclic nucleotide phosphodiesterase (PDE) that catalyzes the hydrolysis of the second messenger cAMP. The encoded protein, which does not hydrolyze cGMP, is resistant to several PDE inhibitors. Defects in this gene are a cause of autosomal dominant striatal degeneration (ADSD). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jul 2010]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO34016 PDE8B Knockout cell line (HeLa) Human PDE8B 1:3~1:6 Negative Online Inquiry
KO34017 PDE8B Knockout cell line (HEK293) Human PDE8B 1:3~1:6 Negative Online Inquiry
KO34018 PDE8B Knockout cell line (A549) Human PDE8B 1:3~1:4 Negative Online Inquiry

Background

PDE8B Gene Knockout Cell Lines are engineered cellular models specifically designed to facilitate the investigation of the phosphodiesterase 8B (PDE8B) gene's role in biological processes and disease mechanisms. By introducing targeted deletions within the PDE8B gene, these knockout cell lines effectively disrupt the normal protein product, allowing researchers to study the resultant physiological and pathological effects in a controlled environment.

The key function of PDE8B involves regulating intracellular levels of cyclic adenosine monophosphate (cAMP), which plays a critical role in several signaling pathways. The knockout of PDE8B leads to elevated cAMP levels, providing valuable insights into cAMP-dependent signaling cascades and their implications in various disease states, including neurodegenerative disorders and metabolic diseases. This model allows researchers to explore how alterations in PDE8B activity impact cellular functions, such as proliferation, apoptosis, and differentiation.

Scientifically, PDE8B Gene Knockout Cell Lines hold significant relevance in both basic research and clinical applications. They serve as essential tools for validating drug targets, testing therapeutic compounds, and elucidating the roles of PDE8B in cancer biology and central nervous system disorders. By utilizing these cell lines, researchers can better understand the connection between PDE8B dysregulation and disease progression, thereby paving the way for the development of novel therapeutic strategies.

What sets our PDE8B Gene Knockout Cell Lines apart from alternatives is their precise genetic modification and validation, ensuring robust reproducibility and reliability of experimental results. Our cell lines are developed using state-of-the-art CRISPR-Cas9 technology, providing researchers with confidence in their findings and facilitating more accurate interpretations of data.

These knockout models are invaluable to researchers and clinicians alike, enhancing our understanding of PDE8B's role in health and disease. By investing in our PDE8B Gene Knockout Cell Lines, you are equipping your research with a powerful tool to drive innovation and discovery in critical areas of biomedical science.

At [Company Name], we pride ourselves on our expertise in developing high-quality, well-characterized biological products. Our commitment to advancing research through superior product offerings exemplifies our dedication to supporting the scientific community's quest for knowledge and breakthroughs.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.